As an individual’s understanding of their genetic risk may influence risk management decisions, it is important to understand the ways in which risk is constructed and interpreted. We systematically reviewed the literature, undertaking a narrative synthesis of 59 studies presenting data on the ways in which individuals perceive, construct and interpret their risk, and the subsequent effects. While most studies assessed perceived risk quantitatively, the combined evidence suggests individuals find risk difficult to accurately quantify, with a tendency to overestimate. Rather than being a stand-alone concept, risk is something lived and experienced and the process of constructing risk is complex and influenced by many factors. While evidence of the effects of perceived risk is limited and inconsistent, there is some evidence to suggest high risk estimations may adversely affect health and lead to inappropriate uptake of medical surveillance and preventative measures by some individuals. A more focused approach to research is needed with greater exploration of the ways in which risk is constructed, along with the development of stronger theoretical models, to facilitate effective and patient-centered counseling strategies.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
Ahl, A. S., Acree, J. A., Gipson, P. S., McDowell, R. M., Miller, L., & McElvaine, M. D. (1993). Standardization of nomenclature for animal health risk analysis. Reviews of Scientific & Technical Office, 12(4), 1045–1053.
Ajzen, I. (1985). From intention to actions: A theory of planned behaviour. In Kuhl, & Beckmann (Eds.) Action-control: From cognition to behavior (pp. 11–39). Heidelberg: Spring.
Ajzen, I. (1991). The theory of planned behavior. Organizational Behavior and Human Decision Processes, 50, 179–211.
AMSTAR (2005). Proposed evaluation tools for COMPUS. Retrieved from https://www.ccohta.ca/compus/compus_pdfs/COMPUS_Evaluation_Methodology_draft_e.pdf.
Andrews, L., Meiser, B., Apicella, C., & Tucker, K. (2004). Psychological impact of genetic testing for breast cancer susceptibility in women of Ashkenazi Jewish background: A prospective study. Genetic Testing, 8(3), 240–247.
Appleton, S., Fry, A., Rees, G., Rush, R., & Cull, A. (2000). Psychosocial effects of living with an increased risk of breast cancer: An exploratory study using telephone focus groups. Psycho-Oncology, 9(6), 511–521.
Axworthy, D., Brock, D. J., Bobrow, M., & Marteau, T. M. (1996). Psychological impact of population-based carrier testing for cystic fibrosis: 3-year follow-up. UK Cystic Fibrosis Follow-Up Study Group. Lancet, 347(9013), 1443–1446.
Beck, A. T., Epstein, N., Brown, G., & Steer, R. A. (1988). An inventory for measuring clinical anxiety: Psychometric properties. Journal of Consultation and Clinical Psychology, 56(6), 893–897.
Berry, D. (2007). Health communication: Theory and practice. Maidenhead: Open University Press.
Binedell, J., Soldan, J. R., & Harper, P. S. (1998). Predictive testing for Huntington’s disease. I. Predictors of uptake in South Wales. Clinical Genetics, 54(6), 477–488.
Bish, A., Sutton, S., Jacobs, C., Levene, S., Ramirez, A., & Hodgson, S. (2002a). Changes in psychological distress after cancer genetic counselling: A comparison of affected and unaffected women. British Journal of Cancer, 86(1), 43–50.
Bish, A., Sutton, S., Jacobs, C., Levene, S., Ramirez, A., & Hodgson, S. (2002b). No news is (not necessarily) good news: Impact of preliminary results for BRCA1 mutation searches. Genetics in Medicine, 4(5), 353–358.
Bottorff, J. L., Ratner, P. A., Johnson, J. L., Lovato, C. Y., & Joab, S. A. (1998). Communicating cancer risk information: The challenges of uncertainty. Patient Education and Counseling, 33(1), 67–81.
Bouman, T., Luteijn, F., Albersnagel, F., & Vanderploeg, F. (1985). Enige ervaringen met de Beck depression inventory (BDI). Gedrag Tijdschr. Psychol, 13, 13–24.
Bowen, D. J., Burke, W., McTiernan, A., Yasui, Y., & Andersen, M. R. (2004). Breast cancer risk counseling improves women’s functioning. Patient Education and Counseling, 53(1), 79–86.
Brain, K., Gray, J., Norman, P., France, E., Anglim, C., & Barton, G., et al. (2000). Randomized trial of a specialist genetic assessment service for familial breast cancer. Journal of the National Cancer Institute, 92(16), 1345–1351.
Brain, K., Norman, P., Gray, J., & Mansel, R. (1999). Anxiety and adherence to breast self-examination in women with a family history of breast cancer. Psychosomatic medicine, 61(2), 181–187.
Brain, K., Norman, P., Gray, J., Rogers, C., Mansel, R., & Harper, P. (2002). A randomized trial of specialist genetic assessment: Psychological impact on women at different levels of familial breast cancer risk. British journal of cancer, 86(2), 233–238.
Braithwaite, D., Emery, J., Walter, F., Prevost, A. T., & Sutton, S. (2004). Psychological impact of genetic counseling for familial cancer: A systematic review and meta-analysis. Journal of the National Cancer Institute, 96(2), 122–133.
Braithwaite, D., Sutton, S., Mackay, J., Stein, J., & Emery, J. (2005). Development of a risk assessment tool for women with a family history of breast cancer. Cancer Detection & Prevention, 29(5), 433–439.
Bringle, R. G., & Antley, R. M. (1980). Elaboration of the definition of genetic counseling into a model for counselee decision-making. Social Biology, 27(4), 304–318.
Broadstock, M., Michie, S., Gray, J., Mackay, J., & Marteau, T. M. (2000). The psychological consequences of offering mutation searching in the family for those at risk of hereditary breast and ovarian cancer—A pilot study. Psycho-Oncology, 9(6), 537–548.
Burke, W., Culver, J. O., Bowen, D., Lowry, D., Durfy, S., & McTiernan, A., et al. (2000). Genetic counseling for women with an intermediate family history of breast cancer. American Journal of Medical Genetics, 90(5), 361–368.
Butow, P. N., Lobb, E. A., Meiser, B., Barratt, A., & Tucker, K. M. (2003). Psychological outcomes and risk perception after genetic testing and counselling in breast cancer: A systematic review. Medical Journal of Australia, 178(2), 77–81.
Callanan, N. P., Bloom, D., Sorenson, J. R., DeVellis, B. M., & Cheuvront, B. (1995). CF carrier testing: Experience of relatives. Journal of Genetic Counseling, 4(2), 83–95.
Case, D. O., Andrews, J. E., Johnson, J. D., & Allard, S. L. (2005). Avoiding versus seeking: The relationship of information seeking to avoidance, blunting, coping, dissonance, and related concepts. Journal of the Medical Library Association, 93(3), 353–362.
Croyle, R. T., & Lerman, C. (1999). Risk communication in genetic testing for cancer susceptibility. Journal of the National Cancer Institute, Monographs, 25, 59–66.
d’Agincourt-Canning, L. (2005). The effect of experiential knowledge on construction of risk perception in hereditary breast/ovarian cancer. Journal of Genetic Counseling, 14(1), 55–69.
Decruyenaere, M., Evers-Kiebooms, G., Boogaerts, A., Cassiman, J. J., Cloostermans, T., & Demyttenaere, K., et al. (1999). Psychological functioning before predictive testing for Huntington’s disease: The role of the parental disease, risk perception, and subjective proximity of the disease. Journal of Medical Genetics, 36(12), 897–905.
Edwards, A., Elwyn, G., Covey, J., Mathews, E., & Pill, R. (2001). Presenting risk information—A review of the effects of ‘framing’ and other manipulations on patient outcomes. Journal of Health Communication, 6, 61–82.
Edwards, A., Sivell, S., Dundon, J., Elwyn, E., Evans, R., Gaff, C., et al. (2006). Effective risk communication in clinical genetics—A systematic review. Report to: Department of Health: Genetics Research Program—Health Services Research (Grant HSR03A; ISBN 0-9550975-2-5): Cardiff Centre for Health Sciences Research, Cardiff University.
Ekwo, E. E., Seals, B. F., Kim, J. O., Williamson, R. A., & Hanson, J. W. (1985). Factors influencing maternal estimates of genetic risk. American Journal of Medical Genetics, 20(3), 491–504.
Evans, D. G., Blair, V., Greenhalgh, R., Hopwood, P., & Howell, A. (1994). The impact of genetic counselling on risk perception in women with a family history of breast cancer. British Journal of Cancer, 70(5), 934–938.
Evers-Kiebooms, G., Denayer, L., Cassiman, J. J., & van den Berghe, H. (1988). Family planning decisions after the birth of a cystic fibrosis child. The impact of prenatal diagnosis. Scandinavian Journal of Gastroenterology—Supplement, 143, 38–46.
Fanos, J. H., & Gatti, R. A. (1999). A mark on the arm: Myths of carrier status in sibs of individuals with ataxia-telangiectasia. American Journal of Medical Genetics, 86(4), 338–346.
Frost, S., Myers, L. B., & Newman, S. P. (2001). Genetic screening for Alzheimer’s disease: What factors predict intentions to take a test. Behavioral Medicine, 27(3), 101–109.
Frost, C. J., Venne, V., Cunningham, D., & Gerritsen-McKane, R. (2004). Decision making with uncertain information: Learning from women in a high risk breast cancer clinic. Journal of Genetic Counseling, 13(3), 221–236.
Frost, M. H., Walsh Vockley, C., Suman, V. J., Greene, M. H., Zahasky, K., & Hartmann, L. (2000). Perceived familial risk of cancer: Health concerns and psychosocial adjustment. Journal of Psychosocial Oncology, 18(1), 63–82.
Gagnon, P., Massie, M. J., Kash, K. M., Gronert, M., Heerdt, A. S., & Brown, K., et al. (1996). Perception of breast cancer risk and psychological distress in women attending a surveillance program. Psycho-Oncology, 5(3), 259–269.
Gates, E. A. (2004). Communicating risk in prenatal genetic testing. Journal of Midwifery & Women’s Health, 49(3), 220–227.
Gigerenzer, G. (1996). The psychology of good judgement: Frequency formats and simple algorithms. Medical Decision Making, 16(3), 273–280.
Gigerenzer, G., & Edwards, A. (2003). Simple tools for understanding risks: From innumeracy to insight. British Medical Journal, 327(7417), 741–744.
Goldberg, D. (1972). The detection of psychiatric illness by questionnaire. London: Oxford University Press.
Gooding, H. C., Organista, K., Burack, J., & Bowles Biesecker, B. (2006). Genetic susceptibility testing from a stress and coping perspective. Social Science & Medicine, 62, 1880–1890.
Harper, P. (2004). Practical Genetic Counselling (6th ed.). London: Arnold.
Hallowell, N., Foster, C., Eeles, R., Ardern-Jones, A., & Watson, M. (2004). Accommodating risk: Responses to BRCA1/2 genetic testing of women who have had cancer. Social Science & Medicine, 59(3), 553–565.
Hallowell, N., Green, J. M., Statham, H., Murton, F., & Richards, M. P. M. (1997). Recall of numerical risk estimates and counsellees’ perceptions of the importance of risk information following genetic counselling for breast and ovarian cancer. Psychology, Health and Medicine, 2(2), 149–159.
Hallowell, N., Statham, H., & Murton, F. (1998). Women’s understanding of their risk of developing breast/ovarian cancer before and after genetic counseling. Journal of Genetic Counseling, 7(4), 345–364.
Hofferbert, S., Worringen, U., Backe, J., Ruckert, E. M., White, K., & Faller, H., et al. (2000). Simultaneous interdisciplinary counseling in German breast/ovarian cancer families: First experiences with patient perceptions, surveillance behavior and acceptance of genetic testing. Genetic Counseling, 11(2), 127–146.
Hopwood, P. (2000). Breast cancer risk perception: What do we know and understand. Breast Cancer Research, 2(6), 387–391.
Hopwood, P., Howell, A., Lalloo, F., & Evans, G. (2003). Do women understand the odds? Risk perceptions and recall of risk information in women with a family history of breast cancer. Community Genetics, 6(4), 214–223.
Hopwood, P., Keeling, F., Long, A., Pool, C., Evans, G., & Howell, A. (1998). Psychological support needs for women at high genetic risk of breast cancer: Some preliminary indicators. Psycho-Oncology, 7(5), 402–412.
Hopwood, P., Shenton, A., Lalloo, F., Evans, D. G. R., & Howell, A. (2001). Risk perception and cancer worry: An exploratory study of the impact of genetic risk counselling in women with a family history of breast cancer . Journal of Medical Genetics, 38(2), 139–142.
Huiart, L., Eisinger, F., Stoppa-Lyonnet, D., Lasset, C., Nogues, C., & Vennin, P., et al. (2002). Effects of genetic consultation on perception of a family risk of breast/ovarian cancer and determinants of inaccurate perception after the consultation. Journal of Clinical Epidemiology, 55(7), 665–675.
Iredale, R., Oates-Whitehead, R., & Gray, J. (2002). Genetic service delivery for individuals at risk of familial breast cancer [protocol]. Cochrane Database of Systematic Reviews, (3).
Janssens, A. C. J. W., Gwinn, M., Valdez, R., Narayan, K. M. V., & Khoury, M. J. (2006). Predictive genetic testing for type 2 diabetes. British Medical Journal, 333, 509–510.
Julian-Reynier, C., Eisinger, F., Chabal, F., Aurran, Y., Bignon, Y. J., & Nogues, C., et al. (1998). Cancer genetic clinics: Why do women who already have cancer attend. European Journal of Cancer, 34(10), 1549–1553.
Katapodi, M. C., Lee, K. A., Facione, N. C., & Dodd, M. J. (2004). Predictors of perceived breast cancer risk and the relation between perceived risk and breast cancer screening: A meta-analytic review. Preventive Medicine, 38(4), 388–402.
Keenan, K. F., Simpson, S. A., Wilson, B. J., van Teijlingen, E. R., McKee, L., & Haites, N., et al. (2005). ‘It’s their blood not mine’: Who’s responsible for (not) telling relatives about genetic risk. Health, Risk & Society, 7(3), 209–226.
Kelly, K., Leventhal, H., Andrykowski, M., Toppmeyer, D., Much, J., & Dermody, J., et al. (2005). Using the common sense model to understand perceived cancer risk in individuals testing for BRCA 1/2 mutations. Psycho-Oncology, 14(1), 34–48.
Kenen, R., Ardern-Jones, A., & Eeles, R. (2003). Family stories and the use of heuristics: Women from suspected hereditary breast and ovarian cancer (HBOC) families. Sociology of Health and Illness, 25(7), 838–865.
Kenen, R., Arden-Jones, A., & Eeles, R. (2004). We are talking, but are they listening? Communication patterns in families with a history of breast/ovarian cancer (HBOC). Psycho-Oncology, 13(5), 335–345.
Khoury, M. J. (2003). Genetics and genomics in practice: The continuum from genetic disease to genetic information in health and disease. Genetics in Medicine, 5(4), 261–268.
Langston, A. L., Robertson, J. M., Robertson, C., Campbell, M. K., Entwistle, V. A., & Marteau, T. M., et al. (2006). Protocol for stage 1 of the GaP study (Genetic testing acceptability for Paget’s disease of bone): An interview study about genetic testing and preventative treatment: Would relatives of people with Paget’s disease want testing and treatment if they were available. BMC Health Services Research, 8(6), 71.
Laux, L., Glanzman, P., Schaffner, P., & Spielberger, C. (1981). Das State-Trait-Angstinventar (STAI). Weinheim: Beltz Tesgesellschaft.
Leonard, K. P., Bartholomew, L., Swank, P. R., & Parcel, G. S. (1995). A comparison of two approaches to education about carrier testing for cystic fibrosis. Journal of Genetic Counseling, 4(2), 97–113.
Lerman, C., Rimer, B. K., & Engstrom, P. F. (1991). Cancer risk notification: Psychosocial and ethical implications. Journal of Clinical Oncology, 9(7), 1275–1282.
Leventhal, H., Meyer, D., & Nerenz, D. (1980). The common-sense representation of illness danger. In Rachman (Ed.) Medical Psychology (vol. vol. 2, (pp. 7–30)). New York: Pergamon.
Liede, A., Metcalfe, K., Hanna, D., Hoodfar, E., Snyder, C., & Durham, C., et al. (2000). Evaluation of the needs of male carriers of mutations in BRCA1 or BRCA2 who have undergone genetic counseling. American Journal of Human Genetics, 67(6), 1494–1504.
Lim, J., Macluran, M., Price, M., Bennett, B., & Butow, P. (2004). Short- and long-term impact of receiving genetic mutation results in women at increased risk for hereditary breast cancer. Journal of Genetic Counseling, 13(2), 115–133.
Loader, S., Shields, C. G., & Rowley, P. T. (2004). Impact of genetic testing for breast-ovarian cancer susceptibility. Genetic Testing, 8(1), 1–12.
Lobb, E. A., Butow, P. N., Meiser, B., Barratt, A., Gaff, C., & Young, M. A., et al. (2003). Women’s preferences and consultants’ communication of risk in consultations about familial breast cancer: Impact on patient outcomes. Journal of Medical Genetics, 40(5), e56.
Marteau, T., & Bekker, H. (1992). The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI). British Journal of Clinical Psychology, 31(3), 301–306.
Marteau, T. M., French, D. P., Griffin, S. J., Prevost, A. T., Sutton, S. R., & Watkinson, C. (2007). Communicating genetic risk information for increasing risk-reducing behaviours [protocol] The Cochrane Database of Systematic Reviews 2007 (in press).
Marteau, T. M., Saidi, G., Goodburn, S., Lawton, J., Michie, S., & Bobrow, M. (2000). Numbers or words? A randomized controlled trial of presenting screen negative results to pregnant women. Prenatal Diagnosis, 20(9), 714–718.
Marteau, T. M., & Weinman, J. (2006). Self-regulation and the behavioral response to DNA risk information: A theoretical analysis and framework for future research. Social Science & Medicine, 62(6), 1360–1368.
McInerney-Leo, A., Biesecker, B. B., Hadley, D. W., Kase, R. G., Giambarresi, T. R., & Johnson, E., et al. (2005). BRCA1/2 testing in hereditary breast and ovarian cancer families II: Impact on relationships. American Journal of Medical Genetics Part A, 133(2), 165–169.
Meiser, B. (2005). Psychological impact of genetic testing for cancer susceptibility: An update of the literature. Psycho-Oncology, 14(12), 1060–1074.
Meiser, B., & Dunn, S. (2000). Psychological impact of genetic testing for Huntington’s disease: An update of the literature. Journal of Neurology, Neurosurgery and Psychiatry, 69(5), 574–578.
Meiser, B., & Halliday, J. L. (2002). What is the impact of genetic counselling in women at increased risk of developing hereditary breast cancer? A meta-analytic review. Social Science & Medicine, 54(10), 1463–1470.
Morris, K. T., Johnson, N., Krasikov, N., Allen, M., & Dorsey, P. (2001). Genetic counseling impacts decision for prophylactic surgery for patients perceived to be at high risk for breast cancer. American Journal of Surgery, 181(5), 431–433.
Newman, J. E., Sorenson, J. R., DeVellis, B. M., & Cheuvront, B. (2002). Gender differences in psychosocial reactions to cystic fibrosis carrier testing. American Journal of Medical Genetics, 113(2), 151–157.
Nordin, K., Björk, J., & Berglund, G. (2004). Factors influencing intention to obtain a genetic test for a hereditary disease in an affected group and in the general public. Preventive Medicine, 39, 1107–1114.
Parsons, E., & Atkinson, P. (1993). Genetic risk and reproduction. Sociological Review, 41(4), 679–706.
Parsons, E. P., Beale, V., Bennett, H., Jones, J., & Lycett, E. J. (2000). Reassurance through surveillance in the face of clinical uncertainty: The experience of women at risk of familial breast cancer. Health Expectations, 3(4), 263–273.
Parsons, E. P., & Clarke, A. J. (1993). Genetic risk: Women’s understanding of carrier risks in Duchenne muscular dystrophy. Journal of Medical Genetics, 30(7), 562–566.
Parsons, E. P., Clarke, A. J., & Bradley, D. M. (2003). Implications of carrier identification in newborn screening for cystic fibrosis. Archives of Disease in Childhood Fetal & Neonatal Edition, 88(6), F467–F471.
Peshkin, B. N., Schwartz, M. D., Isaacs, C., Hughes, C., Main, D., & Lerman, C. (2002). Utilization of breast cancer screening in a clinically based sample of women after BRCA1/2 testing. Cancer Epidemiology, Biomarkers & Prevention, 11(10 Pt 1), 1115–1118.
Pieterse, A. H., Ausems, M. G., Van Dulmen, A. M., Beemer, F. A., & Bensing, J. M. (2005). Initial cancer genetic counseling consultation: Change in counselees’ cognitions and anxiety, and association with addressing their needs and preferences. American Journal of Medical Genetics, 137 A(1), 27–35.
Plon, S. E., Peterson, L. E., Friedman, L. C., & Richards, C. S. (2000). Mammography behavior after receiving a negative BRCA1 mutation test result in the Ashkenazim: A community-based study. Genetics in Medicine, 2(6), 307–311.
Radloff, L. (1977). The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1, 385–401.
Resta, R., Bowles Biesecker, B., Bennett, R. L., Blum, S., Estabrooks Hahn, S., & Strecker, M. N., et al. (2006). A new definition of genetic counseling: National Society of Genetic Counselors’ Task Force Report. Journal of Genetic Counseling, 15(2), 77–83.
Reyna, V. F., & Adam, M. B. (2003). Fuzzy-trace theory, risk communication, and product labeling in sexually transmitted diseases. Risk Analysis, 23(2), 325–342.
Roberts, J. S., Cupples, L. A., Relkin, N. R., Whitehouse, P. J., & Green, R. C. (2005). Genetic risk assessment for adult children of people with Alzheimer’s disease: The risk evaluation and education for Alzheimer’s Disease (REVEAL) Study. Journal of Geriatric Psychiatry and Neurology, 18(4), 250–255.
Robertson, A. (2000). Embodying risk, embodying political rationality: Women’s accounts of risks for breast cancer. Health, Risk & Society, 2(2), 219–235.
Robins Wahlin, T. B., Backman, L., Lundin, A., Haegermark, A., Winblad, B., & Anvret, M. (2000). High suicidal ideation in persons testing for Huntington’s disease. Acta Neurologica Scandinavica, 102(3), 150–161.
Romero, L. J., Garry, P. J., Schuyler, M., Bennahum, D. A., Qualls, C., & Ballinger, L., et al. (2005). Emotional responses to APO E genotype disclosure for Alzheimer disease. Journal of Genetic Counseling, 14(2), 141–150.
Rothemund, Y., Paepke, S., & Flor, H. (2001). Perception of risk, anxiety, and health behaviors in women at high risk for breast cancer. International Journal of Behavioral Medicine, 8(3), 230–239.
Royak-Schaler, R., Klabunde, C. N., Greene, W. F., Lannin, D. R., DeVellis, B., & Wilson, K. R., et al. (2002). Communicating breast cancer risk: Patient perceptions of provider discussions. Medscape Womens Health, 7(2), 2.
Ryan, E. L., & Skinner, C. S. (1999). Risk beliefs and interest in counseling: Focus-group interviews among first-degree relatives of breast cancer patients. Journal of Cancer Education, 14(2), 99–103.
Sagi, M., Kaduri, L., Zlotogora, J., & Peretz, T. (1998). The effect of genetic counseling on knowledge and perceptions regarding risks for breast cancer. Journal of Genetic Counseling, 7(5), 417–434.
Scott, S., Prior, L., Wood, F., & Gray, J. (2005). Repositioning the patient: The implications of being ‘at risk’. Social Science & Medicine, 60(8), 1869–1879.
Shaw, C., Abrams, K., & Marteau, T. M. (1999). Psychological impact of predicting individuals’ risks of illness: A systematic review. Social Science & Medicine, 49, 1571–1598.
Sheinfeld Gorin, S., & Albert, S. M. (2003). The meaning of risk to first degree relatives of women with breast cancer. Women & Health, 37(3), 97–114.
Shiloh, S. (2006). Illness representations, self-regulation, and genetic counseling: A theoretical review. Journal of Genetic Counseling, 15(5), 325–337.
Smith, J. A., Michie, S., Stephenson, M., & Quarrell, O. (2002). Risk perception and decision-making processes in candidates for genetic testing for Huntington’s disease: An interpretative phenomenological analysis. Journal of Health Psychology, 7(2), 131–144.
Spielberger, C. (1983). Manual for the State-Trait Anxiety Inventory STAI (Form Y). Palo Alto, CA: Consulting Psychologists Press.
Spielberger, C., Gorsuch, R., & Lushene, R. (1970). Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press.
Swerts, A. (1987). Impact of genetic counseling and prenatal diagnosis for Down syndrome and neural tube defects. Birth Defects: Original Article Series, 23(2), 61–83.
Van der Ploeg, H., Defares, P., & Spielberger, C. (1980). Handleiding bij de Zelf-Beoordelings Vragenlijst, ZBV [Manual for the Dutch adaptation of the STAI-Y]. Lisse: Swets & Zeitlinger.
van Dijk, S., Otten, W., van Asperen, C. J., Timmermans, D. R., Tibben, A., & Zoeteweij, M. W., et al. (2004). Feeling at risk: How women interpret their familial breast cancer risk. American Journal of Medical Genetics Part A, 131(1), 42–49.
van Dijk, S., Otten, W., Zoeteweij, M. W., Timmermans, D. R., van Asperen, C. J., & Breuning, M. H., et al. (2003). Genetic counselling and the intention to undergo prophylactic mastectomy: Effects of a breast cancer risk assessment. British Journal of Cancer, 88(11), 1675–1681.
van Vliet, H. A., Grimes, D. A., Popkin, B., & Smith, U. (2001). Lay persons’ understanding of the risk of Down’s syndrome in genetic counselling. BJOG: An International Journal of Obstetrics & Gynaecology, 108(6), 649–650.
Walter, F. M., & Emery, J. (2006). Perceptions of family history across common diseases: A qualitative study in primary care. Family Practice, 23(4), 472–480.
Watson, M., Duvivier, V., Wade Walsh, M., Ashley, S., Davidson, J., & Papaikonomou, M., et al. (1998). Family history of breast cancer: What do women understand and recall about their genetic risk? Journal of Medical Genetics, 35(9), 731–738.
Weinstein, N. D. (1999). What does it mean to understand risk? Evaluating risk comprehension. Journal of the National Cancer Institute Monographs, 25, 15–20.
Wertz, D. C., Janes, S. R., Rosenfield, J. M., & Erbe, R. W. (1992). Attitudes toward the prenatal diagnosis of cystic fibrosis: Factors in decision making among affected families. American Journal of Human Genetics, 50(5), 1077–1085.
Wilson, B. J., Torrance, N., Mollison, J., Wordsworth, S., Gray, J. R., & Haites, N. E., et al. (2005). Improving the referral process for familial breast cancer genetic counselling: Findings of three randomised controlled trials of two interventions. Health Technology Assessment, 9(3), iii–iv 1–126.
Yesavage, J., Brink, T., Rose, T., Lum, O., Huang, V., & Adey, M., et al. (1983). Development and validation of a geriatric depression screening scale: A preliminary report. Journal of Psychiatric Research, 17(1), 37–49.
Young, D., McLeish, L., Sullivan, F., Pitkethly, M., Reis, M., & Goudie, D., et al. (2006). Familial breast cancer: Management of ‘lower risk’ referrals. British Journal of Cancer, 95, 974–978.
Zigmond, A., & Snaith, R. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67, 361–370.
The authors would like to thank all members of the GENVIEW steering group, especially Alastair Kent, Melissa Winter, Jonathon Gray, Paul Atkinson and Nicholas Lench. Particular thanks go to Engy Hussein for her administrative support throughout the project. This project was funded by the Department of Health in the UK (Grant HSR03A). There are no conflicts of interest.
Rights and permissions
About this article
Cite this article
Sivell, S., Elwyn, G., Gaff, C.L. et al. How Risk is Perceived, Constructed and Interpreted by Clients in Clinical Genetics, and the Effects on Decision Making: Systematic Review. J Genet Counsel 17, 30–63 (2008). https://doi.org/10.1007/s10897-007-9132-1
- Genetic counseling
- Risk communication
- Risk perception
- Decision making
- Risk management
- Systematic review